Effect of candesartan on cause-specific mortality in heart failure patients: The candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program (vol 110, pg 2180, 2004)

被引：0
|
作者：
Solomon
机构：
来源：
CIRCULATION | 2005年 / 111卷 / 03期
关键词：
D O I：
10.1161/01.CIR.0000155486.26868.C9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [1] Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
    Solomon, SD
    Wang, DL
    Finn, P
    Skali, H
    Zornoff, L
    McMurray, JJV
    Swedberg, K
    Yusuf, S
    Granger, CB
    Michelson, EL
    Pocock, S
    Pfeffer, MA
    [J]. CIRCULATION, 2004, 110 (15) : 2180 - 2183
  • [2] Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
    Ducharme, Anique
    Swedberg, Karl
    Pfeffer, Marc A.
    Cohen-Solal, Alain
    Granger, Christopher B.
    Maggioni, Aldo P.
    Michelson, Eric L.
    McMurray, John J. V.
    Olsson, Lars
    Rouleau, Jean L.
    Young, James B.
    Olofsson, Bertil
    Puu, Margareta
    Yusuf, Salim
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01) : 86 - 92
  • [3] Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
    Preiss, David
    Zetterstrand, Sofia
    McMurray, John J. V.
    Ostergren, Jan
    Michelson, Eric L.
    Granger, Christopher B.
    Yusuf, Salim
    Swedberg, Karl
    Pfeffer, Marc A.
    Gerstein, Hertzel C.
    Sattar, Naveed
    [J]. DIABETES CARE, 2009, 32 (05) : 915 - 920
  • [4] Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program (vol 152, pg 84, 2006)
    Ducharme, A.
    Swedberg, K.
    Pfeffer, M.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (02) : 354 - 354
  • [5] Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program
    Desai, AS
    Swedberg, K
    Mcmurray, JJV
    Granger, CB
    Yusut, S
    Young, JB
    Dunlap, ME
    Solomon, SD
    Hainer, JW
    Olotsson, B
    Michelson, EL
    Pfeffer, MA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 52A - 52A
  • [6] Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity
    Bortman, Guillermo
    Perrone, Sergio V.
    [J]. INSUFICIENCIA CARDIACA, 2006, 1 (01) : 11 - 22
  • [7] Cardioprotection through Candesartan in heart failure CHARM-overall-part assessment -: (Candesartan in heart failure assessment of reduction in mortality and morbidity)
    Nitschmann, S.
    Tschoepe, C.
    Schultheiss, H. -P.
    [J]. INTERNIST, 2006, 47 (10): : 1084 - 1086
  • [8] The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) program
    Pocock, S
    Wang, DL
    Wilhelmsen, L
    Hennekens, CH
    [J]. AMERICAN HEART JOURNAL, 2005, 149 (05) : 939 - 943
  • [9] Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    O'Meara, E
    Lewis, E
    Granger, C
    Dunlap, ME
    McKelvie, RS
    Probstfield, JL
    Young, JB
    Michelson, EL
    Ostergren, J
    Carlsson, J
    Olofsson, B
    McMurray, J
    Yusuf, S
    Swedberg, K
    Pfeffer, MA
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (04) : 650 - 656
  • [10] Angiotensin receptor blockade with candesartan in heart failure:: findings from the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    Ostergren, Jan B.
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : S3 - S7
12345